Announcements Trials
Browse Landscape

Phase

Phase 2/3 3Phase 2 3Phase NA 1Phase 3 1

Status

Active not recruiting 3Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 6NETWORK 1INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 8

Conditions

Breast Neoplasms 8Triple Negative Breast Neoplasms 1Locally Advanced HER2-negative Breast Cancer 1Hyperthermia 1Hematologic Neoplasms 1Hematologic Diseases 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Breast Neoplasms × AC protocol × Clear all
NCT05889390 2026-05-15

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting
71 enrolled
Breast

Hyperthermia, Breast Neoplasms

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT05959889 2026-03-09

Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer

Damanhour University

Phase NA Completed
50 enrolled
Breast

Breast Neoplasms

NCT02096588 2024-07-09

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
34 enrolled 11 charts
Breast

Breast Neoplasms

NCT01057069 2022-10-12

neo-TN

The Netherlands Cancer Institute

Phase 2/3 Active not recruiting
310 enrolled
Breast

Breast Neoplasms

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

GlaxoSmithKline

Phase 2 Completed
101 enrolled 16 charts
Breast

Breast Neoplasms

NCT01917578 2013-08-06

BCSMANC

Shandong Cancer Hospital and Institute

Phase 3 Unknown
4 enrolled
Breast

Breast Neoplasms

NCT01415336 2011-08-11

AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer

Peking Union Medical College Hospital

Phase 2/3 Unknown
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡